Evaluation of the effects of chronic treatment with venlafaxine (150 mg) and pregabalin (200 mg) on emotional indices of anxiety and panic induced by breathing carbon dioxide.
Phase of Trial: Phase IV
Latest Information Update: 01 Feb 2013
At a glance
- Drugs Pregabalin (Primary) ; Venlafaxine (Primary)
- Indications Generalised anxiety disorder; Panic disorder
- Focus Therapeutic Use
- 03 Aug 2011 New trial record